InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Lubniewski John L, Chairman & CEO. Insider active across 1 company, notably HTG Molecular Diagnostics, INC. Aggregated, 9 disclosures have been recorded. Activity tracked since 10 June 2021. The latest transaction was filed on 9 December 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lubniewski John L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
1,000 shares@ US$0.4252.6% of flowCommon StockSEC:0001209191-22-061008:0
61 shares@ US$1.030.4% of flowCommon StockSEC:0001209191-22-040338:0
1,000 shares@ US$0.4763.0% of flowCommon StockSEC:0001209191-22-036957:0
62 shares@ US$1.390.9% of flowCommon StockSEC:0001209191-22-022364:0
62 shares@ US$5.423.6% of flowCommon StockSEC:0001209191-22-000830:0
1,000 shares@ US$3.561538.1% of flowCommon StockSEC:0001209191-21-069771:0
62 shares@ US$5.713.7% of flowCommon StockSEC:0001209191-21-059000:0
62 shares@ US$5.813.7% of flowCommon StockSEC:0001209191-21-045179:0
1,000 shares@ US$3.918538.9% of flowCommon StockSEC:0001209191-21-040442:0
9 of 9 declarations
About Lubniewski John L
Lubniewski John L is Président-Directeur Général and President & CEO of HTG Molecular Diagnostics, INC. He has 9 filings in total, and the 9 sampled filings cover the period from 2021-06-14 to 2022-12-13, with the dominant transaction nature listed as tax withholding; the highest individual amounts in the sampled filings are 3219.126087519421, 3153.636996616357, 448.2444678315699, 402.4750267721491, 305.8626646949639, and 303.8095403220132 euros.
